N-aroylated isatins: Antiglycation activity

Letters in Drug Design and Discovery

Volumn 7, Issue 3, 2010, Pages 188-193

  Khan, Khalid Mohammed ^a   Mughal, Uzma Rasool ^a   Khan, Ambreen ^a   Naz, Farzana ^a   Perveen, Shahnaz ^b   Choudhary, M Iqbal ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b PCSIR LABORATORIES COMPLEX   (Pakistan)

Author keywords

Antiglycation; Isatin; Lead molecules; N aroylation

Indexed keywords

1 (2 FLUOROBENZOYL) 1H INDOLE 2,3 DIONE DERIVATIVE; 1 (3 CHLOROBENZOYL) 1H INDOLE 2,3 DIONE DERIVATIVE; 1 (3 METHYLBENZOYL) 1H INDOLE 2,3 DIONE DERIVATIVE; 1 (4 CHLOROBENZOYL) 1H INDOLE 2,3 DIONE DERIVATIVE; 1 BENZOYL 1H INDOLE 2,3 DIONE DERIVATIVE; AMINOGUANIDINE; ISATIN DERIVATIVE; UNCLASSIFIED DRUG;

ANTIGLYCATION ACTIVITY; AROYLATION; ARTICLE; CHEMICAL REACTION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG STRUCTURE; DRUG SYNTHESIS; IC 50; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; STRUCTURE ACTIVITY RELATION; SUBSTITUTION REACTION;

EID: 77949699174     PISSN: 15701808     EISSN: None     Source Type: Journal    
DOI: 10.2174/157018010790596597     Document Type: Article

References (39)

1. Ahmed, N. Advanced glycation endproducts role in pathology of diabetic complications. Diabetes Res. Clin. Pract., 2005, 67, 3-21.
2. Maillard, L.-C. Réaction générale des acides aminés sur les sucres. J. Physiol., 1912, 14, 813.
3. Billaud, C.; Adrian, J. Louis-Camille Maillard, 1878-1936. Food Rev. Int., 2003, http://www.informaworld.com/smpp/title~content= t713597252~db= all~tab=issueslist~branches=19 - v1919, 345-374.
4. Matsuura, N.; Aradate, T.; Sasaki, C.; Kojima, H.; Ohara. M.; Hasegawa, J.; Ubukata, M. Screening system for the Maillard reaction inhibitor from natural product extracts. J. Health Sci., 2002, 48, 520-526.
5. Nakagawa, T.; Yokozawa, T.; Terasawa, K.; Shu, S.; Juneja, L. R. Screening system for the Maillard reaction inhibitor from natural product extracts. J. Agric. Food Chem., 2002, 50, 2418-2422.
6. a) Freire, A. P.; Ferreira, A.; Gomes, R.; Cordeiro, C. Antiglycation defences in yeast. Biochem. Soc. Trans., 2003, 31, 1409-1412
7. b) Rout, S.; Banerjee, R. Free radical scavenging, antiglycation and tyrosinase inhibition properties of a polysaccharide fraction isolated from the rind from Punica granatum. Bioresour. Technol., 2007, 98, 3159-3163.
8. Joshi, K. C.; Joshi, R. Fluorinated indole derivatives: Synthetic and biomedicinal aspects. J. Indian Chem. Soc., 2000, 77, 627-634.
9. Atta-ur-Rehman.; Ijaz, A. S.; Choudhary, M. I.; Amtul, Z.; Atta-ur-Rahman. New isatin derivatives and their antimicrobial activity. J. Chem. Soc. Pak., 1997, 19, 230-235.
10. Da Silva, J. F. M.; Garden, S. J.; Pinto, A. C. The Chemistry of Isatins: A Review. From 1975 to 1999. J. Braz. Chem. Soc., 2001, 12, 273-324 and references quoted therein.
11. Kahveci, B. Synthesis of 4-amino-4,5-dihydro-1H-1,2,4-triazole-5- ones and their isatin-3-imine derivatves. Molecules, 2005, 10, 376-382.
12. Mashelkar, U. C.; Rane, D. M. Synthesis of some isatin based novel spiroheterocycles and their biological activity studies. J. Indian Chem., 2005, 44 B, 1937-1939.
13. Bouhfid, R.; Joly, N.; Massoui, M.; Cecchelli, R.; Lequart, V.; Martin, P.; Essassi, El. M. An efficient synthesis of new spiro[indolo-3(1H), 2(3'H)-oxadiazolyl] and 1-(triazol-4-ylmethyl)isatin. Heterocycles, 2005, 65, 2949-2955.
14. Popp, F. D. Potential anticonvulsants. Some isatin hydrazones and related compounds. J. Heterocycl. Chem., 1984, 21, 1641-1645.
15. Sriram, D.; Bal, T. R.; Yogeeswari, P. Newer aminopyrimidinimino isatin analogues as non-nucleoside HIV-1 reverse transcriptase inhibitors for HIV and other opportunistic infections of AIDS: design, synthesis and biological evaluation. IL Farmaco, 2005, 60, 377-384.
16. Abele, E.; Abele, R.; Dzenitis, O.; Lukevics, E. Indole and isatin oxime: Synthesis, reactions, and biological activity. Chem. Heterocycl. Compd., 2003, 39, 3-35.
17. Pandeya, S. N.; Raja, A. Y. Synthesis of isatin semicarbazones as novel anticonvulsants role of hydrogen bonding. J. Pharm. Pharm. Sci., 2002, 5, 266-271.
18. Sridhar, S. K.; Saravanan, M.; Ramesh, A. Synthesis and antibacterial screening of hydrazones, Schiff and Mannich bases of isatin derivatives. Eur. J. Med. Chem., 2001, 36, 615-625.
19. Sridhar, S. K.; Ramesh, A. Synthesis and pharmacological activities of hydrazones, Schiff and Mannich bases of isatin derivatives. Biol. Pharm. Bull., 2001, 24, 1149-1152.
20. Alam, M.; Younas, M.; Zafar, M. A.; Naeem. An improved synthesis of isatin. Pak. J. Sci. Ind. Res., 1989, 32, 246.
21. Smolders, R. R.; Waefelaer, A.; Francart, D. 7-Fluoroisatin. Ing. Chim. (Brussels), 1982, 64, 5-6.
22. Sandmeyer, T. Isonitrosoacetanilides and their condensation to form isatin derivatives. Helv. Chim. Acta, 1919, 2, 234-242.
23. Popp, F. D. The chemistry of isatin. Adv. Heterocycl. Chem., 1975, 18, 1-58 and references quoted therein.
24. Sarangapani, M.; Reddy, N. A.; Jayamma, Y.; Reddy, V. M. Synthesis and pharmacological activity of new isatin hydrazones. Indian Drugs, 1998, 35, 336-343.
25. a) Sarangapani, M.; Reddy, V. M. Synthesis and Screening of isatin-3-[N2-(alkoxyethyloxy) acetyl hydrazones. Indian Drugs., 1999, 36, 357-362,
26. b) Sarangapani, M.; Reddy, V. M. Phramacological Evaluation of 1-(N,N-Disubstituted aminomethyl)-3-imino-(2-phenyl-3,4-dihydro-4-oxo- quinazo-lin-3-yl)indolin-2-ones. Indian J. Pharm. Sci., 1996, 58, 147-149.
27. a) Sarangapani, M.; Reddy, V. M. Pharmacological screening of isatin-(N-(2-alkylbenzoxazole-5-carbonyl)) hydrazone. Indian J. Pharm. Sci., 1997, 59, 105-109,
28. b) Popp, F. D.; Parson, R.; Donigan, B. E., Potential anticonvulsants III. The condensation of isatin with cyclic ketones. J. Heterocycl. Chem., 1980, 17, 1329-1340,
29. c) Popp, F. D.; Parson, R.; Donigan, B. E., Synthesis of potential anticonvulsants: Condensation of isatins with acetone and related ketones. J. Pharm. Sci., 1980, 69, 1235-1237,
30. d) Pajouhesh, H.; Parson, R.; Popp, F. D. Potential anticonvulsants VI: Condensation of isatins with cyclohexanone and other cyclic ketones. J. Pharm. Sci., 1983, 72, 318-321,
31. e) Popp, F. D.; Pajouhesh, H. Potential anticonvulsants IV: Condensation of isatin with benzoylacetone and isopropyl methyl ketone. J. Pharm. Sci., 1982, 71, 1052-1054,
32. f) Bhattacharya, S. K. Dose-related proconvulsant and anticonvulsant activity of isatin, a putative biological factor in rat. Indian J. Exp. Biol., 1998, 36, 118-121.
33. Singh, G. S.; Singh, T.; Lakhan, R. C-13 NMR and anticonvulsant activity of new isatin based spiroazetidinones. Indian J. Chem., 1997, 36B, 951-954.
34. a) Lingaiah, N.; Narendra, R.; Dattatray, A. M. Synthesis of some novel 1-aminomethyl-3-benzoylhydrazone-2-indolinones as potential antiinflammatory agents. Indian J. Chem., 1998, 37B, 1254-1257
35. b) Andreani, A; Maselli. Anti-inflammatory activity of Nbenzoyl-isatinic acids and N-p-chlorobenzoyl isatinic acids. Boll. Chim. Farm., 1977, 116, 493-495.
36. Medvedec, A. E.; Clow, A. Sandler, M.; Glover, V. Isatin: A link between natriuretic peptides and monoamines. Biochem. Pharmacol., 1996, 52, 385-391.
37. b) Glover, V.; Halket, J. M.; Watkins, P. J.; Clone A.; Goodwin, B.; Sandler, A. J. Isatin: identity with the purified endogenous monoamine oxidase inhibitor tribulin. Neurochem., 1998, 51, 656-569.
38. Panova, N. G.; Zemskova, M. A.; Axenova, L. N.; Medevedev, A. E. Does isatin interact with rat brain monoamine oxidases in vivo. Neurosci. Lett., 1997, 233, 58-60.
39. Yamaguchi, F.; Ariga, T.; Yoshimura, Y.; Nakazawa, H. Antioxidative and antiglycation activity of garcinol from Garcinia indica fruit Rind. J. Agric. Food Chem., 2000, 48, 180-185.